Bristol-Myers Squibb Co. (BMY) PT Raised to $68 at Societe Generale

March 27, 2019 1:23 PM
Societe Generale analyst Justin Smith raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $68.00 (from $60.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change